SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-271471
Filing Date
2023-11-06
Accepted
2023-11-06 17:22:59
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d551267ds3.htm S-3 198248
2 EX-5.1 d551267dex51.htm EX-5.1 5017
3 EX-23.1 d551267dex231.htm EX-23.1 1665
4 EX-23.2 d551267dex232.htm EX-23.2 1698
5 EX-FILING FEES d551267dexfilingfees.htm EX-FILING FEES 23513
6 GRAPHIC g551267g05e84.jpg GRAPHIC 30108
7 GRAPHIC g551267g22x09.jpg GRAPHIC 94557
  Complete submission text file 0001193125-23-271471.txt   403276
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1900
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275353 | Film No.: 231380839
SIC: 2834 Pharmaceutical Preparations